CRISPR Gene Editing Newsletter
Issue #33April 20, 20267 studies

Base editing corrected 60% of liver cells in mice with rare genetic disease

CRISPR's gene-editing toolkit keeps expanding, and this week brought major advances in treating genetic diseases, cancer, and infections. From correcting rare disorders in living animals to engineering smarter immune cells, researchers are pushing the boundaries of precision medicine.

🎯 Base editing rescues liver disease in mice with rare genetic disorder

  • Scientists used base editing to correct up to 60% of liver cells in mice with Zellweger spectrum disorder, a rare genetic disease that causes liver failure and neurological problems

  • The treatment eliminated toxic fatty acid buildup in blood, liver, and brain tissue while normalizing liver function and helping mice gain weight

  • In human patient cells, base editing corrected over 80% of the disease-causing genetic variants and restored normal cellular function

Why it matters: This represents a major step toward treating genetic diseases at their root cause rather than just managing symptoms, with minimal off-target effects detected.

πŸ₯‡ Top 1% journal πŸ”— Nature biomedical engineering Journal Article πŸ—“οΈ Apr 14

Key Findings

🧬 Gene editing without toxic conditioning cures immune deficiency in mice

  • Researchers combined base editing with a non-toxic antibody treatment to cure severe combined immunodeficiency (SCID) in mice

  • The approach avoided the dangerous chemotherapy typically needed for stem cell transplants while successfully restoring immune cell production

  • Even with low editing efficiency, the treatment generated normal B-cell development and immune function

πŸ’‘ This could eliminate the life-threatening side effects of current SCID treatments while maintaining the cure.
πŸ₯ˆ Top 2% journal πŸ”— Mol Ther Journal Article πŸ—“οΈ Apr 13

πŸ”¬ New technique boosts precise gene editing by 41-fold

  • A new method called ESS-HDR increased precise gene editing efficiency by 7-16 fold in lab-grown cells and 41-fold in primary skin cells

  • The technique works by coupling desired edits with essential gene repairs, so only cells that undergo accurate editing survive

  • Unlike existing methods, it requires no drugs or permanent genetic markers, making it safer for therapeutic use

πŸ’‘ This addresses one of gene therapy's biggest challenges: getting precise edits to work efficiently enough for clinical use.
πŸ₯ˆ Top 2% journal πŸ”— Genome research Journal Article πŸ—“οΈ Apr 15

πŸ’‘ Methylation-sensitive CRISPR targets cancer cells while sparing healthy tissue

  • Scientists developed ThermoCas9, a CRISPR variant that only works when DNA methylation patterns are disruptedβ€”a hallmark of many cancers

  • The system efficiently targeted genes that are consistently unmethylated in breast cancer patients while avoiding methylated healthy tissue

  • Structural analysis revealed exactly how methylation blocks the enzyme's activity, providing a blueprint for engineering more selective tools

πŸ’‘ This adds a new layer of precision to gene editing by exploiting cancer's altered DNA methylation patterns.
πŸ”— Nature Journal Article πŸ—“οΈ Apr 15

🎯 Base editing transforms immune cells into better cancer killers

  • Editing a single gene (TIGIT) in natural killer cells achieved over 90% efficiency and dramatically enhanced their ability to kill cancer cells

  • The modification converted an inhibitory signal into an activating one, amplifying the cells' cancer-fighting power

  • Cryopreserved edited cells worked as well as fresh ones, supporting development as an "off-the-shelf" cancer therapy

πŸ’‘ This simple genetic tweak could make natural killer cell therapy more potent against multiple cancer types.
πŸ₯ˆ Top 2% journal πŸ”— Cancer research Journal Article πŸ—“οΈ Apr 15

πŸ”¬ CRISPR screen reveals new target for pancreatic cancer treatment

  • A genome-wide screen identified SIRT7 as a key protein that silences the tumor suppressor MEN1 in pancreatic neuroendocrine tumors

  • Blocking SIRT7 restored MEN1 expression, impaired DNA repair, and significantly enhanced radiation therapy effectiveness

  • SIRT7 levels were elevated in patient tumors and correlated with worse outcomes

πŸ’‘ Targeting SIRT7 could make radiation therapy more effective for pancreatic cancers that are notoriously hard to treat.
πŸ₯ˆ Top 2% journal πŸ”— Advanced science (Weinheim, Baden-Wurttemberg, Germany) Journal Article πŸ—“οΈ Apr 13

πŸ§ͺ RNA-targeting CRISPR eliminates 97% of eye cancer cells

  • CRISPR-Cas13d targeting the RASGRP3 gene killed over 97% of uveal melanoma cells while sparing healthy eye cells

  • The approach worked through two mechanisms: directly destroying the essential RNA and triggering broader RNA degradation

  • Uveal melanoma has had no improvement in survival rates for over 50 years, making this a potential breakthrough

πŸ’‘ This RNA-targeting strategy could finally provide a treatment option for a cancer with dismal outcomes.
πŸŽ–οΈ Top 10% journal πŸ”— Molecular therapy. Oncology Journal Article πŸ—“οΈ Apr 17

Implications

This week's research shows CRISPR moving from experimental tool to precision medicine platform. Base editing is proving especially powerful for treating genetic diseases by making exact corrections rather than crude cuts, while new targeting strategies are making gene editing both more efficient and more selective.

Studies in this issue

Primary sources used for this newsletter.

  1. Base editing in living mice improves liver problems and cell cleaning defects in a model of Zellweger spectrum disorder
    main storyNature biomedical engineering2026-04-14PMID 41981313
  2. Blocking SIRT7 may reduce radiation resistance in pancreatic neuroendocrine tumors by restoring MEN1 activity
    key findingAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026-04-13PMID 41972414
  3. How Cas9 changes its DNA editing based on methylation
    key findingNature2026-04-15PMID 41986708
  4. Highly efficient and scar-free genome editing using repair linked to essential genes
    key findingGenome research2026-04-15PMID 41985988
  5. A gene-editing treatment that selectively removes eye melanoma cancer cells
    key findingMolecular therapy. Oncology2026-04-17PMID 41994560
  6. Changing TIGIT in Natural Killer Cells Alters CD155 Signals to Improve Cancer Immunotherapy
    key findingCancer research2026-04-15PMID 41982126
  7. Restoring the immune system using precise gene editing and gentle preparation in mice with a Rag2 mutation
    key findingMolecular therapy : the journal of the American Society of Gene Therapy2026-04-13PMID 41968583

Continue reading

All CRISPR Gene Editing issues